Pegaptanib
Information about Pegaptanib
Pegaptanib Uses
Pegaptanib is used in the treatment of wet age-related macular degeneration.
How Pegaptanib works
Pegaptanib is a monoclonal antibody. It works in cancer by stopping the formation of blood vessels that bring oxygen and nutrients to cancerous cells. This may slow the growth and spread of cancer.
Common side effects of Pegaptanib
Punctate keratitis, High blood pressure, Conjunctival hemorrhage, Cataract, Increased intraocular pressure, Eye pain, Corneal edema, Blurred vision, Eye discomfort, Eyelid inflammation, Diarrhea, Nausea, Anterior chamber inflammation, Eye discharge, Eye irritation, Reduced visual acuity, Visual disturbance, Vitreous floaters, Vitreous opacities, Vitreous haemorrhage, Conjunctivitis, Photopsia (presence of perceived flashes of light), Bronchitis (inflammation of the airways), Dizziness, Headache, Urinary tract infection, Corneal epithelial disorders, Joint inflammation, Diabetes, Chest pain, Contact dermatitis, Carotid artery disease
Available Medicine for Pegaptanib
MacugenPfizer Ltd
₹445711 variant(s)
Expert advice for Pegaptanib
- Pegaptanib is used for the treatment of an eye condition called wet age-related macular degeneration.
- It is administered directly into the eyeball by an eye specialist.
- It may cause temporary visual disturbances. Don't drive or do anything that requires mental focus until you know how Pegaptanib affects you.
- Inform your doctor if you experience increased eye pain and redness, blurred or decreased vision, or increased sensitivity to light.